Banco Santander, S.A. Vertex Pharmaceuticals Inc Transaction History

Banco Santander, S.A.

$8.06 Billion
Q2 2024

A detailed history of Banco Santander, S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Banco Santander, S.A. holds 16,428 shares of VRTX stock, worth $8.25 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

16,428

Previous 16,953 3.1%

Holding current value

$8.25 Million

Previous $7.09 Million 8.66%

% of portfolio

0.1%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$392.81 - $485.53 $206,225 - $254,903	-525 Reduced 3.1%	16,428 $7.7 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $1.4 Million - $1.54 Million	-3,442 Reduced 16.88%	16,953 $7.09 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $740,880 - $887,068	-2,160 Reduced 9.58%	20,395 $8.3 Million
Q3 2023 Nov 08, 2023	SELL	$338.18 - $362.46 $463,306 - $496,570	-1,370 Reduced 5.73%	22,555 $7.84 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $1.74 Million - $1.95 Million	-5,530 Reduced 18.77%	23,925 $8.42 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $2.23 Million - $2.55 Million	-7,880 Reduced 21.11%	29,455 $9.28 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $1.18 Million - $1.33 Million	-4,135 Reduced 9.97%	37,335 $10.8 Million
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $314,904 - $351,359	-1,150 Reduced 2.7%	41,470 $12 Million
Q2 2022 Jul 28, 2022	SELL	$234.96 - $292.55 $2.95 Million - $3.68 Million	-12,572 Reduced 22.78%	42,620 $12 Million
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $1.76 Million - $2.07 Million	7,930 Added 16.78%	55,192 $14.4 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $230,113 - $290,485	1,300 Added 2.83%	47,262 $10.4 Million
Q3 2021 Nov 08, 2021	BUY	$181.39 - $202.99 $7.81 Million - $8.73 Million	43,030 Added 1467.6%	45,962 $8.34 Million
Q2 2021 Jul 29, 2021	SELL	$187.49 - $221.1 $248,236 - $292,736	-1,324 Reduced 31.11%	2,932 $591,000
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $73,906 - $86,147	357 Added 9.16%	4,256 $914,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $3.03 Million - $4.04 Million	-14,622 Reduced 78.95%	3,899 $921,000
Q3 2020 Nov 09, 2020	SELL	$255.65 - $303.1 $27.5 Million - $32.6 Million	-107,431 Reduced 85.3%	18,521 $5.04 Million
Q2 2020 Aug 05, 2020	SELL	$225.48 - $295.8 $10.9 Million - $14.3 Million	-48,443 Reduced 27.78%	125,952 $36.6 Million
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $15 Million - $18.6 Million	74,906 Added 75.29%	174,395 $41.5 Million
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $12.7 Million - $17 Million	75,993 Added 323.43%	99,489 $21.8 Million
Q3 2019 Nov 06, 2019	SELL	$166.23 - $187.09 $15.8 Million - $17.8 Million	-95,083 Reduced 80.19%	23,496 $3.98 Million
Q2 2019 Aug 07, 2019	SELL	$164.61 - $190.37 $38.8 Million - $44.9 Million	-235,594 Reduced 66.52%	118,579 $21.7 Million
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $147,029 - $174,840	-898 Reduced 0.25%	354,173 $65.2 Million
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $16,254 - $20,566	-107 Reduced 0.03%	355,071 $58.8 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $322,712 - $370,831	1,924 Added 0.54%	355,178 $68.5 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $2.01 Million - $2.35 Million	13,799 Added 4.07%	353,254 $60 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $402,498 - $470,280	2,655 Added 0.79%	339,455 $55.3 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $1.35 Million - $1.52 Million	9,800 Added 3.0%	336,800 $50.5 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $48.4 Million - $53.1 Million	327,000	327,000 $49.7 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Vertex Pharmaceuticals Inc Transaction History